Lindbrook Capital, LLC Neogenomics Inc Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 216 shares of NEO stock, worth $3,831. This represents 0.0% of its overall portfolio holdings.

Number of Shares

216

Previous 216 -0.0%

Holding current value

$3,831

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$13.01 - $15.77 $1,886 - $2,286	145 Added 204.23%	216 $2,000
Q1 2024 Apr 25, 2024	SELL	$14.06 - $16.79 $2,685 - $3,206	-191 Reduced 72.9%	71 $1,000
Q4 2023 Jan 31, 2024	BUY	$11.67 - $20.73 $2,228 - $3,959	191 Added 269.01%	262 $4,000
Q1 2023 Apr 26, 2023	SELL	$9.09 - $19.45 $563 - $1,205	-62 Reduced 46.62%	71 $1,000
Q4 2022 Jan 24, 2023	SELL	$6.45 - $12.07 $4,702 - $8,799	-729 Reduced 84.57%	133 $0
Q3 2022 Nov 10, 2022	BUY	$7.86 - $12.91 $2,224 - $3,653	283 Added 48.88%	862 $7,000
Q2 2022 Aug 01, 2022	SELL	$7.06 - $13.97 $5,196 - $10,281	-736 Reduced 55.97%	579 $5,000
Q1 2022 Apr 21, 2022	SELL	$12.15 - $35.28 $14,033 - $40,748	-1,155 Reduced 46.76%	1,315 $16,000
Q4 2021 Jan 18, 2022	BUY	$30.49 - $48.49 $75,310 - $119,770	2,470 New	2,470 $84,000
Q2 2021 Jul 27, 2021	SELL	$36.62 - $51.69 $9,155 - $12,922	-250 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$41.56 - $59.88 $6,234 - $8,982	150 Added 150.0%	250 $12,000
Q4 2020 Jan 27, 2021	BUY	$36.08 - $56.47 $2,525 - $3,952	70 Added 233.33%	100 $5,000
Q3 2020 Nov 03, 2020	BUY	$33.26 - $40.48 $997 - $1,214	30 New	30 $1,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.23B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Neogenomics Inc Transaction History